Cancer biomarkers
Biomarkers are molecules that indicate normal or abnormal process taking place in your body and may be a sign of an underlying condition or disease.
- Cancer biomarkers usually refer to proteins, genes, and other molecules that affect how cancer cells grow, multiply, die, and respond to other compounds in the body.
- Biomarkers may be detected and measured to develop a personalised treatment plan.
What is tumour profiling?
A molecular profile reveals unique characteristics of a person’s disease at the molecular level.
- Caris uses multiple technologies to provide very specific information about the molecular and genetic makeup of your tumour.
- It provides doctors with knowledge about which treatments are most likely to produce the best results.
How does tumour profiling inform cancer treatment?
In recent years, increasing numbers of oncologists have adopted precision medicine as a treatment approach for various cancers that have historically been characterised and treated based on body location.
- This approach has been aided by the development of molecular profiling that can help doctors personalise treatment plans for individual patients.
- Examples of therapies informed by molecular profiling include biomarkers that trigger cells to grow and multiply abnormally, biomarkers that support a treatment’s cellular or molecular action, and many more.
Created: February 20, 2018 - Modified: June 28, 2019